Boreal Genomics
Vancouver · Founded 2007
About Boreal Genomics
Boreal is committed to improving cancer patient care through the development of research tools and diagnostic tests based on the monitoring of tumor mutations from cell-free DNA in plasma. It also provides novel DNA enrichment and library construction solutions for high accuracy sequencing in liquid biopsy applications. The company's OnTarget platform performs highly sensitive mutation detection to enable accurate tumor profiling and real-time monitoring of tumor evolution from cell-free DNA in plasma. The OnTarget assay is available as a research-use service to reveal tumor mutations that are undetectable with other methods and may help guide selection of therapy, improve clinical trial efficiency, and accelerate drug development programs. Boreal Genomics was founded in 2007 and is based in Vancouver, BC, Canada.
Company Facts
- Founded: 2007
- Legal name: Boreal Genomics, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $24.6M
- Funding stage: Late Stage Venture
- Last round: Secondary Market (Mar 2019)
- Website: borealgenomics.com
- Phone: 604-822-8268
Social Profiles
Canonical: https://fsome.com/organization/boreal-genomics-8272130 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.